Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.
Zoppoli G, Garuti A, Cirmena G, di Cantogno LV, Botta C, Gallo M, Ferraioli D, Carminati E, Baccini P, Curto M, Fregatti P, Isnaldi E, Lia M, Murialdo R, Friedman D, Sapino A, Ballestrero A.
Zoppoli G, et al. Among authors: friedman d.
J Transl Med. 2017 May 1;15(1):91. doi: 10.1186/s12967-017-1195-7.
J Transl Med. 2017.
PMID: 28460632
Free PMC article.